Federated Hermes
GOSS icon

Federated Hermes’s Gossamer Bio GOSS Stock Holding History

Federated Hermes’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,065,136
Closed -$3.02M – 2124
2024
Q3 		$3.02M Hold
3,065,136
– – 0.01% 841
2024
Q2 		$2.76M Sell
3,065,136
-67,978
-2% -$50.9K 0.01% 849
2024
Q1 		$3.85M Sell
3,133,114
-73,346
-2% -$80.7K 0.01% 783
2023
Q4 		$2.93M Sell
3,206,460
-788,263
-20% -$582K 0.01% 850
2023
Q3 		$3.33M Buy
3,994,723
+3,057,419
+326% +$3.52M 0.01% 796
2023
Q2 		$1.12M Sell
937,304
-3,101
-0.3% -$3.86K ﹤0.01% 1109
2023
Q1 		$1.18M Buy
940,405
+238,711
+34% +$457K ﹤0.01% 1119
2022
Q4 		$1.52M Sell
701,694
-1,496,621
-68% -$12.3M ﹤0.01% 1001
2022
Q3 		$26.3M Sell
2,198,315
-1,328,163
-38% -$16.5M 0.08% 315
2022
Q2 		$29.5M Hold
3,526,478
– – 0.08% 299
2022
Q1 		$30.6M Buy
3,526,478
+564,236
+19% +$5.44M 0.07% 342
2021
Q4 		$33.5M Buy
2,962,242
+8
+0% +$95 0.06% 357
2021
Q3 		$37.2M Buy
2,962,234
+34
+0% +$313 0.07% 341
2021
Q2 		$24.1M Sell
2,962,200
-500,000
-14% -$4.34M 0.04% 439
2021
Q1 		$32M Sell
3,462,200
-2,280
-0.1% -$23K 0.06% 378
2020
Q4 		$33.5M Buy
3,464,480
+1,445,443
+72% +$14.2M 0.07% 334
2020
Q3 		$25.1M Buy
2,019,037
+124,479
+7% +$1.65M 0.06% 367
2020
Q2 		$24.6M Buy
1,894,558
+377,358
+25% +$4.75M 0.06% 350
2020
Q1 		$15.4M Buy
1,517,200
+365,000
+32% +$4.77M 0.05% 390
2019
Q4 		$18M Buy
1,152,200
+220,771
+24% +$4.45M 0.04% 438
2019
Q3 		$15.6M Hold
931,429
– – 0.04% 428
2019
Q2 		$20.7M Buy
931,429
+193,429
+26% +$3.7M 0.05% 343
2019
Q1 		$16M Buy
+738,000
New +$15.4M 0.04% 405

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Federated Hermes's GOSS Position: Q4 2024 in Review

Federated Hermes sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 3,065,136 shares — an estimated $3.02M sold.

Federated Hermes first reported a position in GOSS in Q1 2019 and held it in 23 quarters. The position peaked at $37.2M in Q3 2021. 105 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • Federated Hermes reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • Federated Hermes sold 3,065,136 Gossamer Bio shares in Q4 2024, an estimated $3.02M.
  • Federated Hermes first reported a position in Gossamer Bio in Q1 2019 and held it in 23 quarters.
  • Federated Hermes's Gossamer Bio position peaked at $37.2M in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.